Global Wound Care Biologics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Wound Care Biologics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.
Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
Wound Care Biologics report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Wound Care Biologics market is projected to reach US$ 8092.5 million in 2034, increasing from US$ 3940 million in 2022, with the CAGR of 10.7% during the period of 2024 to 2034. Demand from Acute Wounds and Chronic Wounds are the major drivers for the industry.
Global Wound Care Biologics key players include Smith and Nephew, Organogenesis, MiMedx, Integra, Osiris, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, having a total share about 35 percent.
In terms of product, Biologic Skin Substitutes is the largest segment, with a share about 55%. And in terms of application, the largest application is Chronic Wounds, followed by Acute Wounds, Surgical Wounds.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Wound Care Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Smith and Nephew
Organogenesis
MiMedx
Integra
Osiris
Derma Sciences, Inc
Soluble Systems
Amnio Technology, LLC
Medline
Skye® Biologics
Alphatec Spine,Inc.
Pinnacle Transplant Technologies
Segment by Type
Biologic Skin Substitutes
Enzyme Based Formulations
Growth Factors
Acute Wounds
Chronic Wounds
Surgical Wounds
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Wound Care Biologics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Wound Care Biologics introduction, etc. Wound Care Biologics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Wound Care Biologics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
Wound Care Biologics report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Wound Care Biologics market is projected to reach US$ 8092.5 million in 2034, increasing from US$ 3940 million in 2022, with the CAGR of 10.7% during the period of 2024 to 2034. Demand from Acute Wounds and Chronic Wounds are the major drivers for the industry.
Global Wound Care Biologics key players include Smith and Nephew, Organogenesis, MiMedx, Integra, Osiris, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, having a total share about 35 percent.
In terms of product, Biologic Skin Substitutes is the largest segment, with a share about 55%. And in terms of application, the largest application is Chronic Wounds, followed by Acute Wounds, Surgical Wounds.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Wound Care Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Smith and Nephew
Organogenesis
MiMedx
Integra
Osiris
Derma Sciences, Inc
Soluble Systems
Amnio Technology, LLC
Medline
Skye® Biologics
Alphatec Spine,Inc.
Pinnacle Transplant Technologies
Segment by Type
Biologic Skin Substitutes
Enzyme Based Formulations
Growth Factors
Segment by Application
Acute Wounds
Chronic Wounds
Surgical Wounds
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Wound Care Biologics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Wound Care Biologics introduction, etc. Wound Care Biologics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Wound Care Biologics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices